| Bioactivity | SARS-CoV-2-IN-106 (compound 19) is a SARS-CoV-2 papain-like protease inhibitor with the IC50 values of 0.44 μM and 0.18 μM for PLpro enzymatic and viral replication ,respectively[1]. |
| CAS | 2863607-73-0 |
| Formula | C31H38FN5O2 |
| Molar Mass | 531.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Shan H, et al. Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2. Cell Chem Biol. 2021;28(6):855-865.e9. |
SARS-CoV-2-IN-106
CAS: 2863607-73-0 F: C31H38FN5O2 W: 531.66
SARS-CoV-2-IN-106 (compound 19) is a SARS-CoV-2 papain-like protease inhibitor with the IC50 values of 0.44 μM and 0.18
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.